Added to YB: 2026-10-05
Pitch date: 2026-10-01
CVX.PA [neutral]
Carvolix SA
-10.42%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Carvolix SA, a medical technology company, develops and markets minimally invasive, minimally invasive medical devices in the field of urology and structural heart in France.
Market Cap
EUR 342.4M
Pitch Price
EUR 5.76
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
N/A
EV/Sales
N/A
Sector
Health Care Equipment and Supplies
Category
growth
Carvolix (CVX France): Regulatory milestones approach
CVX.PA (update): Carvolix could move from clinical development into initial commercialization as TAVIPILOT’s European software certification and US robotic-system decision approach. Strong early clinical results support the opportunity, while €20m raised during H1 and €30m of bond financing extend financing into 2027. H1 cash burn nearly doubled to €13m, however, and commercial execution and further funding needs remain unresolved.
Read full article (2 min)